Literature DB >> 23466245

Effect of neoadjuvant chemotherapy on outcomes of immediate free autologous breast reconstruction.

M V Schaverien1, D A Munnoch.   

Abstract

BACKGROUND: Neoadjuvant chemotherapy (NC) is increasingly being utilised although the effects on outcomes of free autologous breast reconstruction and adjuvant treatment remain unclear. The aim of this study was to examine the effect of NC on complications following immediate free flap breast reconstruction.
METHODS: A prospective study of immediate free flap breast reconstructions comparing patients who received NC with those who did not was conducted in a single specialist regional unit.
RESULTS: Eighty-seven patients (95 flaps) were included in the study, 30 of which (35 flaps) received NC followed by free flap breast reconstruction. Twenty patients in the NC group had one or more complications compared with 37 patients in the control group (p = 0.87). Nine patients in the NC group had more than one complication compared with 11 patients in the control group, although this difference was not significant (p = 0.26). Both obesity (p = 0.016) and current cigarette smoking (p = 0.014) were significantly associated with the occurrence of any complication in patients who had received NC. Adjuvant radiotherapy was delayed in 3 patients in the NC group, and adjuvant chemotherapy was delayed in 3 control patients (p = 1). The mean preoperative haemoglobin was significantly lower in the NC group than in the control group (p = 0.00037), although there was no significant difference in blood transfusion requirements.
CONCLUSIONS: Patients undergoing immediate autologous breast reconstruction following NC have a similar complication and reoperation rate to patients not receiving NC. Preoperative blood haemoglobin level was found to be significantly lower following NC and postoperative blood transfusion triggers should take this into account.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23466245     DOI: 10.1016/j.ejso.2013.02.015

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

Review 1.  Breast reconstruction following conservative mastectomies: predictors of complications and outcomes.

Authors:  Sophocles H Voineskos; Simon G Frank; Peter G Cordeiro
Journal:  Gland Surg       Date:  2015-12

2.  Does neoadjuvant chemotherapy affect morbidity, mortality, reoperations, or readmissions in patients undergoing lumpectomy or mastectomy for breast cancer?

Authors:  Jeffrey Landercasper; Barbara Bennie; Mallory S Bray; Choua A Vang; Jared H Linebarger
Journal:  Gland Surg       Date:  2017-02

Review 3.  Breast Reconstruction Following Cancer Treatment.

Authors:  Bernd Gerber; Mario Marx; Michael Untch; Andree Faridi
Journal:  Dtsch Arztebl Int       Date:  2015-08-31       Impact factor: 5.594

4.  Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction.

Authors:  Nicholas B Abt; José M Flores; Pablo A Baltodano; Karim A Sarhane; Francis M Abreu; Carisa M Cooney; Michele A Manahan; Vered Stearns; Martin A Makary; Gedge D Rosson
Journal:  JAMA Surg       Date:  2014-10       Impact factor: 14.766

Review 5.  Innovative Standards in Surgery of the Breast after Neoadjuvant Systemic Therapy.

Authors:  Tal Hadar; Michael Koretz; Mahmood Nawass; Tanir M Allweis
Journal:  Breast Care (Basel)       Date:  2021-11-02       Impact factor: 2.860

6.  Boomerang latissimus dorsi flap in total breast reconstruction: report of three cases.

Authors:  Myeong Jae Kang; Tae Hyun Park; Jeong Yeop Ryu; Byeongju Kang; Jeeyeon Lee; Ho Yong Park; Jung Dug Yang; Joon Seok Lee
Journal:  Gland Surg       Date:  2022-01

7.  Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study.

Authors:  Jia-Ruei Yang; Wen-Ling Kuo; Chi-Chang Yu; Shin-Cheh Chen; Jung-Ju Huang
Journal:  BMC Cancer       Date:  2021-05-08       Impact factor: 4.430

8.  The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.

Authors:  Rajiv Dave; Rachel O'Connell; Tim Rattay; Zoe Tolkien; Nicola Barnes; Joanna Skillman; Paula Williamson; Elizabeth Conroy; Matthew Gardiner; Adrian Harnett; Ciara O'Brien; Jane Blazeby; Shelley Potter; Chris Holcombe
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

9.  Long-term outcomes of immediate autologous breast reconstruction after definite adjuvant therapy in intermediate and locally advanced breast cancer.

Authors:  Won Sup Yoon; Chai Hong Rim; Dae Sik Yang; Jung Ae Lee; Gil Soo Son; Young Woo Chang; Sang Uk Woo; Deok-Woo Kim; Eun-Sang Dhong
Journal:  Ann Transl Med       Date:  2019-12

10.  Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis.

Authors:  Junlong Song; Xiang Zhang; Qiang Liu; Jianheng Peng; Xinjie Liang; Yuanyuan Shen; Hongtao Liu; Hongyuan Li
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.